Abbonarsi

Staphylococcus aureus impairs sinonasal epithelial repair: Effects in patients with chronic rhinosinusitis with nasal polyps and control subjects - 07/02/19

Doi : 10.1016/j.jaci.2018.05.035 
Fabiana C.P. Valera, MD, PhD a, b, , Manon Ruffin, PhD a, c, , Damien Adam, PhD a, c, Émilie Maillé, MSc a, Badr Ibrahim, MD a, d, Julie Berube, MSc e, Simon Rousseau, PhD e, Emmanuelle Brochiero, PhD a, c, , Martin Y. Desrosiers, MD a, d, ,
a Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada 
b Division of Otorhinolaryngology, Ribeirão Preto Medical School, University of São Paulo (FMRP-USP), Ribeirão Preto, Brazil 
c Département de Médecine, Université de Montréal, Montreal, Quebec, Canada 
d Department of Otolaryngology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada 
e Meakins-Christie Laboratories, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada 

Corresponding author: Martin Y. Desrosiers, MD, Department of Otolaryngology, Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), 900 rue Saint-Denis, Montréal H2X0A9, Québec, Canada.Department of OtolaryngologyCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM)900 rue Saint-DenisMontréalQuébecH2X0A9Canada

Abstract

Background

The effect of Staphylococcus aureus on nasal epithelial repair has never been assessed in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Objective

This study aimed to determine whether (1) nasal epithelial cell cultures from patients with CRSwNP and control subjects repair differently; (2) S aureus exoproducts compromise nasal epithelial repair; (3) S aureus alters lamellipodial dynamics; and (4) deleterious effects could be counteracted by the Rho-associated coiled-coil kinase inhibitor Y-27632.

Methods

Primary nasal epithelial cells (pNECs) collected during surgeries were cultured and injured under 3 conditions: (1) basal conditions, (2) exposed to S aureus exoproducts, and (3) exposed to S aureus exoproducts and Y-27632. Epithelial repair, lamellipodial dynamics, and cytoskeletal organization were assessed.

Results

Under basal conditions, pNEC cultures from patients with CRSwNP presented significantly lower repair rates and reduced lamellipodial protrusion length and velocity than those from control subjects. S aureus exoproducts significantly decreased repair rates and protrusion dynamics in both control subjects and patients with CRSwNP; however, the effect of S aureus on cell protrusions was more sustained over time in patients with CRSwNP. Under basal conditions, immunofluorescence assays showed significantly reduced percentages of cells with lamellipodia at the wound edge in patients with CRSwNP compared with control subjects. S aureus altered cell polarity and decreased the percentage of cells with lamellipodia in both groups. Finally, Y-27632 prevented the deleterious effects of S aureus exoproducts on CRSwNP repair rates, as well as on lamellipodial dynamics and formation.

Conclusions

S aureus exoproducts significantly alter epithelial repair and lamellipodial dynamics on pNECs, and this impairment was more pronounced in patients with CRSwNP. Importantly, Y-27632 restored epithelial repair and lamellipodial dynamics in the presence of S aureus exoproducts.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Il testo completo di questo articolo è disponibile in PDF.

Key Words : Staphylococcus aureus, chronic rhinosinusitis, repair, nasal epithelial cells, lamellipodia, Rho-associated coiled-coil kinase inhibitor, Y-27632

Abbreviations used : CRS, CRSwNP, ESS, LB, pNEC, ROCK, SAinactive


Mappa


 Supported by FAPESP, São Paulo Research Foundation. Brazil (grant no. 2016/00772-1- Scholarship to F.C.V.). The Respiratory Health Network of Québec supported our Respiratory Tissue and Cell Biobank of CRCHUM. This work was supported by the Canadian Institutes of Health Research (CIHR, grant PJT148593 to E.B.), les Fonds de Recherche du Québec en Santé (fellowships to M.R. and D.A.), and CRCHUM and Université de Montréal (scholarship to E.B.).
 Disclosure of potential conflict of interest: F. C. P. Valera has received support from FAPESP, São Paulo Research Foundation, Brazil (grant no. 2016/00772-1). M. Ruffin has received support from les Fonds de Recherche du Québec en Santé (fellowship). D. Adam has received support from les Fonds de Recherche du Québec en Santé (fellowship). É. Maillé has received support from the Respiratory Health Network of Québec for the support of our Respiratory Tissue and Cell Biobank of CRCHUM J. Berube has received support from the Canadian Institutes of Health Research (MOP#123496). S. Rousseau has received support from the Canadian Institutes of Health Research (MOP#123496). E. Brochiero has received support from the Respiratory Health Network of Québec for the support of our Respiratory Tissue and Cell Biobank of CRCHUM, the Canadian Institutes of Health Research (CIHR, grant PJT148593), CRCHUM, and Université de Montréal (scholarship). M. Y. Desrosiers is a member of on an advisory panel at LaurieMed (PolypVac) and is President of ProBionase Therapies. B. Ibrahim declares no relevant conflicts of interest.


© 2018  American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 143 - N° 2

P. 591 - febbraio 2019 Ritorno al numero
Articolo precedente Articolo precedente
  • Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation
  • Zala Jevnikar, Jörgen Östling, Elisabeth Ax, Jenny Calvén, Kristofer Thörn, Elisabeth Israelsson, Lisa Öberg, Akul Singhania, Laurie C.K. Lau, Susan J. Wilson, Jonathan A. Ward, Anoop Chauhan, Ana R. Sousa, Bertrand De Meulder, Matthew J. Loza, Frédéric Baribaud, Peter J. Sterk, Kian Fan Chung, Kai Sun, Yike Guo, Ian M. Adcock, Debbie Payne, Barbro Dahlen, Pascal Chanez, Dominick E. Shaw, Norbert Krug, Jens M. Hohlfeld, Thomas Sandström, Ratko Djukanovic, Anna James, Timothy S.C. Hinks, Peter H. Howarth, Outi Vaarala, Marleen van Geest, Henric Olsson
| Articolo seguente Articolo seguente
  • Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature
  • Kunal Malik, Helen He, Thy Nhat Huynh, Gary Tran, Kelly Mueller, Kristina Doytcheva, Yael Renert-Yuval, Tali Czarnowicki, Shai Magidi, Margaret Chou, Yeriel D. Estrada, Huei-Chi Wen, Xiangyu Peng, Hui Xu, Xiuzhong Zheng, James G. Krueger, Amy S. Paller, Emma Guttman-Yassky

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.